Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
Document › Details

Thermo Fisher Scientific Inc.. (5/4/17). "Press Release: New Licensing Program Facilitates Adoption of Tandem Mass Tag Technology". Carlsbad, CA.

Organisations Organisation Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
  Organisation 2 Cell Signaling Technology Inc. (CST)
  Group Cell Signaling Technology (CST) (Group)
Products Product TMT® (isobaric tandem mass tag) technology
  Product 2 proteomic services
Index term Index term Cell Signaling Technology–Thermo Fisher: TMT technology, 201705– license to use TMT technology for proteomic research services to CST
Persons Person Haghdoost, Navid (Thermo Fisher 201705 Director Protein Biology Product Management)
  Person 2 Polakiewicz, Roberto (Cell Signaling Technology 201705 CSO)

Thermo Fisher Scientific helps research service providers and their customers optimize protein identification and quantitation

Research service providers and their customers are now set to benefit from a new licensing program specifically designed to facilitate and optimize the use of the Thermo Scientific™ Tandem Mass Tag™ protein identification and quantitation technology.

The Thermo Fisher Scientific licensing program enables service providers to leverage the power of Thermo Scientific™ TMT™ technology to cater to the analytical needs of their customers for more reproducible quantitative proteomics. Cell Signaling Technology (CST), a specialized provider of research products and services and an early licensee, is already realizing the benefits of the quantitative multiplex technology.

“There is an increased market demand for the unique analytical capabilities of the TMT technology, as well as for service providers with the necessary skills and equipment to perform that type of analysis. We are very excited about growing the use of this technology and having the ability to offer it through CST’s service business,” said Navid Haghdoost, director, Protein Biology Product Management, Thermo Fisher Scientific.

The TMT technology uses tandem mass spectrometry (MS/MS) to provide consistent and accurate simultaneous identification and quantitation of proteins in up to 10 different samples derived from cells, tissues or biological fluids. The technology features an enhanced multiplex capability resulting in fewer missing quantitative values as the level of TMT multiplexing increases.

“CST is pleased to license TMT technology from Thermo Fisher Scientific, which will add power to our proteomics services by delivering unparalleled quantitative protein analysis. We expect this technology will enable us to help our pharma and academic customers accelerate their pre-clinical discovery research,” said Roberto Polakiewicz, chief scientific officer at CST.

For more information about TMT technology, please visit:

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit

About CST

Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing the world’s highest quality, innovative, research and diagnostic products to accelerate biological understanding and enable personalized medicine. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.

CST Media and Press

Rebecca J. Reppucci, MBA
Cell Signaling Technology, Inc.
Director of Marketing Communications
Phone: 978-867-2382


Record changed: 2023-06-05


Picture EBD Group ChinaBio Partnering Forum 2023 Shanghai 650x200px

More documents for Thermo Fisher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group World of Partnering Opportunities 650x300px

» top